CHICAGO, August 25, 2004 (LifeSiteNews.com) - The Coalition on Abortion/Breast Cancer, an international women’s organization that disseminates information on abortion as a risk factor for breast cancer, deplored the censorship of important scientific research by two medical journals. “Recognition of the [abortion-breast cancer] link could embarrass leading researchers and the cancer fundraising industry,” explained Karen Malec, president of the coalition. “Nevertheless, the increasing incidence and importance of female breast cancer merits the fullest scientific investigation and discussion,” she added. Refusing to publish letters from leading medical researchers were a UK journal, The Lancet, and Cancer Epidemiology, Biomarkers & Prevention, the main publication of the American Association for Cancer Research. The Lancet refused to publish letters from two experts, Chris Kahlenborn, MD and Patrick Carroll. Kahlenborn is the author of Breast Cancer: It’s Link to Abortion and the Birth Control Pill. Carroll is a British actuary and statistician and the research director for the Pension and Population Research Institute in London. Cancer Epidemiology, Biomarkers & Prevention rejected a letter from Joel Brind, Ph.D., professor of endocrinology at Baruch College, City University of New York. Summaries of the censured letters can be accessed at http://www.abortionbreastcancer.com/letters/index.htm jmo